Melexis NV (LON:0FA0)
London · Delayed Price · Currency is GBP · Price in EUR 56.75
-2.00 (-3.40%)
At close: Dec 12, 2025
Melexis NV Market Cap
Melexis NV has a market cap or net worth of 2.03 billion as of December 12, 2025. Its market cap has increased by 8.44% in one year.
Market Cap
2.03B
Enterprise Value
2.25B
Revenue
717.96M
Ranking
n/a
PE Ratio
21.51
Stock Price
56.75
Market Cap Chart
Since March 10, 1998, Melexis NV's market cap has increased from 374.07M to 2.03B, an increase of 443.18%. That is a compound annual growth rate of 6.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 2.03B | 7.64% |
| Dec 31, 2024 | 1.89B | -40.99% |
| Dec 29, 2023 | 3.20B | 10.22% |
| Dec 30, 2022 | 2.90B | -18.38% |
| Dec 31, 2021 | 3.56B | 24.02% |
| Dec 31, 2020 | 2.87B | 26.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.84B |
| HSBC Holdings | 190.77B |
| Shell | 155.38B |
| Unilever | 107.41B |
| Rio Tinto Group | 96.53B |
| British American Tobacco p.l.c. | 95.33B |
| Rolls-Royce Holdings | 92.08B |
| GSK plc | 73.12B |